Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet (2009) 4.79

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology (2010) 2.01

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest (2005) 1.95

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology (2009) 1.93

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology (2010) 1.82

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis. J Neurol Neurosurg Psychiatry (2008) 1.77

HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J Neurol Neurosurg Psychiatry (2014) 1.68

Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol (2010) 1.64

Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res (2008) 1.63

Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses. Cell (2015) 1.60

The initiation and prevention of multiple sclerosis. Nat Rev Neurol (2012) 1.58

Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate. Ann Neurol (2011) 1.55

Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol (2010) 1.45

Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings. Mult Scler (2013) 1.45

The relevance of animal models in multiple sclerosis research. Pathophysiology (2011) 1.40

An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One (2010) 1.36

The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist (2010) 1.28

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler (2011) 1.24

CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis (2012) 1.20

The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One (2009) 1.18

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol (2010) 1.17

Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets (2012) 1.15

Multiple sclerosis genetics--is the glass half full, or half empty? Nat Rev Neurol (2010) 1.15

A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet (2013) 1.15

Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry (2005) 1.13

The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Proc Natl Acad Sci U S A (2002) 1.11

Epstein-barr virus: environmental trigger of multiple sclerosis? J Virol (2007) 1.11

Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol (2003) 1.06

Epigenetic changes in patients with multiple sclerosis. Nat Rev Neurol (2012) 1.05

Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci (2012) 1.04

Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther (2006) 1.01

Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis. PLoS One (2013) 1.00

Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health (2004) 1.00

Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler (2009) 0.99

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol (2010) 0.96

Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis (2010) 0.95

Common viruses associated with lower pediatric multiple sclerosis risk. Neurology (2011) 0.95

Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future. Expert Rev Clin Immunol (2014) 0.94

Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis. Mult Scler (2012) 0.94

Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation. Viruses (2012) 0.93

Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog (2013) 0.92

Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunology (2014) 0.92

Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis. Neurology (2013) 0.91

An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue. J Neurol (2007) 0.91

Human cytomegalovirus and autoimmune disease. Biomed Res Int (2014) 0.90

Viruses and multiple sclerosis. Neuroscientist (2011) 0.90

Serum uric acid and risk of multiple sclerosis. J Neurol (2009) 0.89

Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis. BMC Bioinformatics (2013) 0.88

Is the risk of multiple sclerosis related to the 'biography' of the immune system? J Neurol (2009) 0.87

Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Mol Cell Proteomics (2011) 0.86

Multiple sclerosis and the role of immune cells. World J Exp Med (2014) 0.86

Virus-mediated autoimmunity in Multiple Sclerosis. J Autoimmune Dis (2006) 0.85

Pediatric multiple sclerosis: current concepts and consensus definitions. Autoimmune Dis (2013) 0.83

Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life. Clin Exp Immunol (2006) 0.83

The double-edged sword of autoimmunity: lessons from multiple sclerosis. Toxins (Basel) (2010) 0.83

EBNA1 and LMP1 variants in multiple sclerosis cases and controls. Acta Neurol Scand (2010) 0.83

Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases. Front Immunol (2015) 0.83

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study. BMC Neurol (2011) 0.82

Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis. Clin Exp Immunol (2013) 0.81

Sexual orientation and gender differences in markers of inflammation and immune functioning. Ann Behav Med (2014) 0.81

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol (2016) 0.80

Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women. Autoimmunity (2011) 0.80

XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented? J Neurol Sci (2011) 0.79

Recent advances in genetic predisposition of myasthenia gravis. Biomed Res Int (2013) 0.79

CMV infection attenuates the disease course in a murine model of multiple sclerosis. PLoS One (2012) 0.79

A large-scale seroprevalence of Epstein-Barr virus in Taiwan. PLoS One (2015) 0.78

Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APC. Mol Pharm (2012) 0.78

Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis. PLoS One (2014) 0.77

Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis. Mult Scler (2012) 0.77

The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences. Eur J Microbiol Immunol (Bp) (2011) 0.77

Association of Epstein-Barr virus antibody titers with a human IL-10 promoter polymorphism in Japanese women. J Autoimmune Dis (2008) 0.77

A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis. Sci Rep (2015) 0.76

Cytomegalovirus and multiple sclerosis risk. J Neurol (2013) 0.76

EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature. Med Microbiol Immunol (2015) 0.76

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis. PLoS One (2017) 0.75

Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System. Curr Neuropharmacol (2010) 0.75

Breastfeeding, previous Epstein-Barr virus infection, Enterovirus 71 infection, and rural residence are associated with the severity of hand, foot, and mouth disease. Eur J Pediatr (2013) 0.75

New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity. J Allergy Clin Immunol (2015) 0.75

Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran. Jundishapur J Microbiol (2015) 0.75

EBV seroepidemiology in married and unmarried women and men in Iran. Rep Biochem Mol Biol (2014) 0.75

Prevalence of Cytomegalovirus in Patients With Multiple Sclerosis: A Case-Control Study in Northern Iran. Jundishapur J Microbiol (2016) 0.75

The influence of sodium on pathophysiology of multiple sclerosis. Neurol Sci (2017) 0.75

Viruses and multiple sclerosis. JAMA (2001) 0.75

Immunological fingerprinting method for differentiation of serum samples in research-oriented biobanks. Clin Vaccine Immunol (2010) 0.75

The Role of Latently Infected B Cells in CNS Autoimmunity. Front Immunol (2015) 0.75

Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders. Front Immunol (2017) 0.75

Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clin Transl Immunology (2017) 0.75

The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis. Clin Exp Immunol (2017) 0.75

Marginal structural models and causal inference in epidemiology. Epidemiology (2000) 33.54

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

No hiding place: on the discomforts of researching the contemporary policy process. J Soc Policy (1990) 8.97

Evidence based policymaking. BMJ (1995) 8.08

The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA (1997) 7.42

Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20

Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17

A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med (2000) 6.07

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst (2001) 5.97

Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr (2001) 5.67

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst (2001) 5.33

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31

Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17

Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med (1989) 5.08

Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96

Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81

Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol (1990) 4.80

Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74

Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science (1995) 4.51

A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50

Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49

Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46

Vitamin D intake and incidence of multiple sclerosis. Neurology (2004) 4.39

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34

Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29

Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22

Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med (1997) 4.16

Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med (2001) 3.92

Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst (1995) 3.88

Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology (1999) 3.86

Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med (1999) 3.82

Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS (2001) 3.81

Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79

A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA (1996) 3.79

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76

Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med (1998) 3.73

Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev (1995) 3.70

Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet (1998) 3.69

The validity of recalled weight among younger women. Int J Obes Relat Metab Disord (1995) 3.68

The "redisorganisation" of the NHS. BMJ (2001) 3.52

Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation (1996) 3.40

Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37

Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36

Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med (1995) 3.29

Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ (1996) 3.27

Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA (1999) 3.21

Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage (2006) 3.10

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol (2001) 3.09

Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol (1992) 3.03

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst (1998) 2.97

Fluid intake and the risk of bladder cancer in men. N Engl J Med (1999) 2.93

Dietary factors and the survival of women with breast carcinoma. Cancer (1999) 2.92

Birth weight and adult hypertension and obesity in women. Circulation (1996) 2.92

Epidemiology of interstitial cystitis: a population based study. J Urol (1999) 2.85

The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS (1998) 2.80

Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA (1999) 2.80

Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst (1998) 2.67

One-hit models of carcinogenesis: conservative or not? Risk Anal (1988) 2.67

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

Adiposity and mortality in men. Am J Epidemiol (2000) 2.60